Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation.

Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation.

Item
http://www.wikidata.org/entity/Q34011547
Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells.Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies.The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discoveryNatural compounds with proteasome inhibitory activity for cancer prevention and treatment.Proteasome inhibition as a therapeutic strategy for hematologic malignancies.Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.Proteasome inhibitors in the clinical setting: benefits and strategies to overcome multiple myeloma resistance to proteasome inhibitors.Role of the ubiquitin proteasome system in hematologic malignancies.Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.The role of bortezomib in the treatment of acute lymphoblastic leukemia.Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturationSensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.
P2860

Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation.

Item
http://www.wikidata.org/entity/Q34011547
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@ast
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@en
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@nl
type
label
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@ast
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@en
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@nl
prefLabel
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@ast
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@en
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Ubiquitin-proteasome system an ...... to apoptotic death activation.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921